Brinker Capital Investments, LLC Verona Pharma PLC Transaction History
Brinker Capital Investments, LLC
- $5.01 Billion
- Q4 2022
A detailed history of Brinker Capital Investments, LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Brinker Capital Investments, LLC holds 11,946 shares of VRNA stock, worth $703,858. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,946
Previous 12,326
3.08%
Holding current value
$703,858
Previous $126,000
147.62%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding VRNA
# of Institutions
226Shares Held
67.7MCall Options Held
1.4MPut Options Held
299K-
Perceptive Advisors LLC New York, NY6.39MShares$377 Million9.9% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$329 Million18.53% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$199 Million9.42% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.13MShares$185 Million2.79% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx3.13MShares$184 Million2.81% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $3.59B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...